Unicycive Therapeutics Inc (UNCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,142 | 9,701 | 455 | 16,579 | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 200 |
| TOTAL | $30,948 | $13,399 | $2,644 | $18,411 | $204 |
| Non-Current Assets | |||||
| PPE Net | 75 | 26 | 22 | 28 | N/A |
| Other Non-Current Assets | 645 | 766 | 152 | 305 | 0 |
| TOTAL | $720 | $792 | $174 | $333 | $N/A |
| Total Assets | $31,668 | $14,191 | $2,818 | $18,744 | $204 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 986 |
| Accounts payable and accrued liabilities | 1,058 | 839 | 892 | 742 | 193 |
| Accrued Expenses | 3,562 | 3,234 | 2,237 | 1,212 | 168 |
| Other current liabilities | 18,936 | 13,134 | N/A | N/A | N/A |
| TOTAL | $24,120 | $17,534 | $3,284 | $2,105 | $2,875 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 117 | 466 | 0 | 155 | 0 |
| TOTAL | $117 | $466 | $N/A | $155 | $N/A |
| Total Liabilities | $24,237 | $18,000 | $3,284 | $2,260 | $2,875 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,971 | 3,476 | 1,523 | 1,500 | N/A |
| Common Shares | 114 | 35 | 15 | 15 | 9 |
| Retained earnings | -101,270 | -64,541 | -33,997 | -15,939 | -5,922 |
| TOTAL | $7,431 | $-3,809 | $-466 | $16,484 | $-2,671 |
| Total Liabilities And Equity | $31,668 | $14,191 | $2,818 | $18,744 | $204 |